RxSight - About the company
RxSight is a public company based in Aliso Viejo (United States), founded in 1997. It operates as a Developer of adjustable intraocular lens technology. RxSight has raised $194M in funding from Longitude Capital. The company has 47 active competitors, including 4 funded and 8 that have exited. Its top competitors include companies like Rayner, Nayam Innovations and Care Group.
Company Details
RxSight (formerly known as Calhoun Vision) has developed an adjustable intraocular lens technology. It uses biocompatible materials called macromers which are sensitive to ultraviolet light of a certain wavelength. When irradiated by such light, the macromers undergo photopolymerization, leading to a predictable change in the shape of the lens surface.
- Website
- rxsight.com
- Registered Address
- Aliso Viejo, California
Key Metrics
Founded Year
1997
Location
Aliso Viejo, United States
Stage
Public
Total Funding
$194M in 11 rounds
Latest Funding Round
Investors
Ranked
1st among 47 active competitors
Annual Revenue
$100M - $500M as on Dec 31, 2025
Employee Count
415 as on May 31, 2026
Exit Details
Public
Legal entities associated with RxSight
RxSight is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Rxsight, Inc. CIN: 1111485 , United States, Active | $100M - $500M (As on Dec 31, 2025) | - | - | |
RXSIGHT, INC. CIN: 6267704 , United States, Active | Aug 25, 2021 | - | - | - |
Calhoun Vision, Inc. CIN: 943268801 , United States, Active | Dec 31, 1999 | - | 490 (As on Dec 31, 2024) | - |
RxSight's IPO details
RxSight got listed on Jul 30, 2021.
Click here to take a look at RxSight's IPO in detail
Sign up to download RxSight's company profile
RxSight's funding and investors
RxSight has raised a total funding of $194M over 11 rounds. Its first funding round was on Jul 2002. Its latest funding round was a Conventional Debt round on Dec 02, 2020 for $*****. 1 investor participated in its latest round. RxSight has 11 institutional investors.
Here is the list of recent funding rounds of RxSight:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 02, 2020 | 4721151 | Conventional Debt | 3028667 | 3473492 | 1891665 | 2874925 |
Apr 03, 2017 | 6183965 | Series H | 6053008 | 1620053 | 5336464 | 4970084 |
Mar 2017 | 9007234 | Series H | 9105156 | 5421972 | 8567917 |
View details of RxSight's funding rounds and investors
RxSight's founders and board of directors
Founder? Claim ProfileRxSight's employee count trend
RxSight has 415 employees as of May 26. Here is RxSight's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
RxSight's Competitors and alternates
Top competitors of RxSight include Rayner, Nayam Innovations and Care Group. Here is the list of Top 10 competitors of RxSight, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | RxSight 1997, Aliso Viejo (United States), Public | Developer of adjustable intraocular lens technology | $194M | 63/100 | |
2nd | Rayner 1910, Worthing (United Kingdom), Acquired | Manufacturer of intraocular lenses and ophthalmic devices | - | 57/100 | |
3rd | Nayam Innovations 2012, Pune (India), Seed | Developer of an artificial implantable intraocular lens to treat cataracts | $3.26M | 53/100 | |
4th | Care Group 1987, Vadodara (India), Unfunded | Manufacturer of intraocular lenses and ophthalmic surgical devices. The company produces a variety of intraocular lenses, including conventional, advanced, premium, add-on, and customized lenses, as well as phakic lenses. They also offer ophthalmic solutions, pharmaceutical products, and diagnostic strips. Their product line includes surgical devices and ophthalmic equipment. The company focuses on providing solutions for cataract and refractive surgeries, aiming to deliver spectacle-free vision. Research and development are central to their operations, driving innovation in ophthalmic technology. | - | - | 53/100 |
5th | STAAR Surgical 1982, Monrovia (United States), Public | Manufacturer of implantable lenses for the eye with companion delivery systems | - | 44/100 | |
6th | Biotech Healthcare 1999, Lucerne (Switzerland), Unfunded | Manufacturer of ophthalmic, orthopedic, and aesthetic medical products. The company develops and produces intraocular lenses, viscosupplements, and dermal fillers. Its ophthalmology products support cataract and refractive surgery, while its orthopedics offerings address joint pain and mobility. The aesthetics product line focuses on skin rejuvenation. The company's manufacturing facilities utilize advanced technologies to ensure product quality and efficacy. | - | - | 42/100 |
7th | VSY Biotechnology 1997, Amsterdam (Netherlands), Unfunded | Develops intraocular lens | - | - | 37/100 |
8th | Manufactures innovative intraocular lenses for cataract surgery. | - | 37/100 | ||
9th | WaveTec Vision 1997, Aliso Viejo (United States), Acqui-Hired | Intraoperative guidance system for Intraocular lens alignment during cataract surgery | $85.2M | 36/100 | |
10th | SAV-IOL 2009, Neuchatel (Switzerland), Funding Raised | Customized Intraocular lenses for cataract patients | - | 36/100 |
Looking for more details on RxSight's competitors? Click here to see the top ones
RxSight's Investments and acquisitions
RxSight has made no investments or acquisitions yet.
Reports related to RxSight
Here is the latest report on RxSight's sector:
News related to RxSight
Media has covered RxSight for a total of 29 events in the last 1 year, 4 of them have been about company updates and 2 about people movement.
•
Baillie Gifford & Co. Raises Stock Holdings in RxSight, Inc. $RXSTMarketBeat•Jan 26, 2026•RxSight, Baillie Gifford
•
•
Pomerantz Law Firm Investigates RxSight, Inc. (RXST) for Potential Securities FraudGlobeNewswire•Dec 30, 2025•Pomerantz, RxSight
•
•
•
Berger Montague Advises RxSight Investors to Contact Firm Before September 22, 2025Benzinga•Sep 17, 2025•Berger Montague, RxSight, DJS Law Group, Schall Law Firm and 4 others
•
RxSight, Inc. Shareholder Alert: Bernstein Liebhard LLP Reminds Investors of DeadlineBenzinga•Sep 02, 2025•Bernstein Liebhard, RxSight, Rosenlegal, Levi & Korsinsky and 3 others
•
•
ROSEN Encourages RxSight Investors to Secure Counsel Before Deadline in Class ActionBenzinga•Aug 23, 2025•Rosenlegal, RxSight, Levi & Korsinsky, Bleichmar Fonti & Auld and 2 others
•
Levi & Korsinsky Notifies Shareholders of XPLR Infrastructure, LP of a Class Action LawsuitNewMediaWire•Aug 08, 2025•Levi & Korsinsky, XPLR Infrastructure, NextEra Energy, Rosenlegal and 6 others
Are you a Founder ?
FAQs about RxSight
Explore our recently published companies
- Fdsconsultant - Srinagar based, Unfunded company
- ICS India - Thane based, 2017 founded, Unfunded company
- Ofenbau Silbernagl - Germany based, Unfunded company
- Snowstack - Unfunded company
- VisageMap - Santa Clara based, 2015 founded, Unfunded company
- Aviation Acres - United States based, 2008 founded, Unfunded company